Results 11 to 20 of about 1,674,597 (262)

CT-based tumour response criteria compared after combined treatment for liver metastases of colorectal cancer [PDF]

open access: yes, 2017
open6noPurpose: The aim of this analysis is to compare different tumour response criteria (TRC) after chemotherapy combined with bevacizumab in liver metastases from colorectal cancer (mCRC) to ascertain the best early prognostic indicator of response.
Aliberti, C.   +5 more
core   +1 more source

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. [PDF]

open access: yes, 2016
BackgroundHuman epidermal growth factor receptor 2 (HER2)-positive breast cancer is a particularly aggressive form of the disease, and ultimately progresses in patients with metastases on standard therapies.
Cortes, Javier   +10 more
core   +2 more sources

Credit allocation based on journal impact factor and coauthorship contribution [PDF]

open access: yes, 2016
Some research institutions demand researchers to distribute the incomes they earn from publishing papers to their researchers and/or co-authors.
Contreras-Reyes, Javier E.
core   +2 more sources

Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma [PDF]

open access: yes, 2016
BACKGROUND: This retrospective study aimed to determine how often a perimetric examination should be carried out in order to identify visual field (VF) changes in patients with relatively early manifestation glaucoma.
Abdolrahimzadeh, S   +4 more
core   +1 more source

Early pseudoprogression following chemoradiotherapy in glioblastoma patients: the value of RANO evaluation [PDF]

open access: yes, 2013
Early Pseudo-progression Following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO EvaluationThe aim of this study was to determine the frequency of pseudoprogression in a cohort of glioblastoma (GBM) patients following radiotherapy ...
Carvalho, Bruno   +4 more
core   +2 more sources

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome. [PDF]

open access: yes, 2020
IntroductionDisruption of metabolic function is a recognized feature of late onset Alzheimer's disease (LOAD). We sought to determine whether similar metabolic pathways are implicated in adults with Down syndrome (DS) who have increased risk for ...
Alzheimer's Biomarkers Consortium–Down Syndrome (ABC‐DS) Investigators   +12 more
core  

The Efficiency of Glucocorticoid Therapy in Secondary-progressive Course of Multiple Sclerosis [PDF]

open access: yes, 2018
We have investigated the efficacy of pulse-therapy with glucocorticoids (GC) at different time stages (in debuts, at the recurrent stage and at the stage of progression) of secondary progressive course (SPC) of multiple sclerosis (MS) in 70 patients (57 ...
Vasylovskyy, V. (Vitaliy)
core   +2 more sources

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors [PDF]

open access: yes, 2018
To compare long-term overall survival (OS) in patients with G1 and G2 grade Ta bladder cancer after transurethral resection of bladder tumors (TURBTs).
Balan, Daniel   +16 more
core   +2 more sources

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE) : study protocol for a randomized controlled trial [PDF]

open access: yes, 2012
Background: Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma patients are suitable candidates for treatment with curative intent, such ...
Al Younis, Imad   +11 more
core   +1 more source

Incidence of mild cognitive impairment and dementia in Parkinson's disease: The Parkinson's disease cognitive impairment study [PDF]

open access: yes, 2019
Background: Cognitive impairment in Parkinson's disease (PD) includes a spectrum varying from Mild Cognitive Impairment (PD-MCI) to PD Dementia (PDD). The main aim of the present study is to evaluate the incidence of PD-MCI, its rate of progression to ...
Baschi R.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy